the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
01 September 2018 – The American Food and Drug Administration (FDA) is warning that cases of a very rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes …
Diabetes: No end to SGLT2-inhibitor drugs side effects Read more »
May 06, 2018 – In April 2016 the American Food and Drug Administration (FDA) took regulatory action by mandating label changes with new warnings about an increased risk of heart failure for new diabetes medicines in the dipeptidyl peptidase-4 (DPP-4) …
Heart attacks and stroke: The risk of DPP-4 anti-diabetes drugs Read more »